GlycoMimetics (GLYC) News Today → Trump’s last act as President (From Porter & Company) (Ad) Free GLYC Stock Alerts $1.62 -0.18 (-10.00%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGlycoMimetics (GLYC) Scheduled to Post Earnings on Thursdayamericanbankingnews.com - May 2 at 4:08 AMWe're Keeping An Eye On GlycoMimetics' (NASDAQ:GLYC) Cash Burn Ratefinance.yahoo.com - April 28 at 3:12 PMGlycoMimetics, Inc. (GLYC)finance.yahoo.com - April 27 at 7:47 AMGlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024businesswire.com - April 25 at 7:00 AMGlycoMimetics, Inc. (NASDAQ:GLYC) Sees Significant Growth in Short Interestmarketbeat.com - April 16 at 7:41 AMGlycoMimetics Incmoney.usnews.com - April 15 at 9:18 PMLoss-Making GlycoMimetics, Inc. (NASDAQ:GLYC) Expected To Breakeven In The Medium-Termfinance.yahoo.com - April 1 at 12:36 PMHC Wainwright Comments on GlycoMimetics, Inc.'s Q1 2024 Earnings (NASDAQ:GLYC)marketbeat.com - March 29 at 8:16 AMGlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 28 at 1:41 PMGlycoMimetics, Inc. Expected to Post FY2026 Earnings of $0.14 Per Share (NASDAQ:GLYC)marketbeat.com - March 28 at 8:59 AMPositive Outlook for GlycoMimetics: Buy Rating Affirmed Amid Anticipated Pivotal Trial Results and Strategic Growth Initiativesmarkets.businessinsider.com - March 28 at 2:27 AMQ4 2023 GlycoMimetics Inc Earnings Callfinance.yahoo.com - March 28 at 2:27 AMBuy Rating on GlycoMimetics Backed by Strong Financials and Promising Phase 3 Trial of Uproleselanmarkets.businessinsider.com - March 27 at 9:27 PMBuy Recommendation for GlycoMimetics Based on Promising Upro Drug Prospects and Strong Pipelinemarkets.businessinsider.com - March 27 at 9:27 PMHC Wainwright Reiterates "Buy" Rating for GlycoMimetics (NASDAQ:GLYC)marketbeat.com - March 27 at 2:13 PMGLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023investorplace.com - March 27 at 12:05 PMGlycoMimetics: Q4 Earnings Snapshotsfgate.com - March 27 at 11:26 AMGlycoMimetics Inc (GLYC) Posts Quarterly Loss, Aligns with Analyst Projectionsfinance.yahoo.com - March 27 at 11:26 AMGlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023businesswire.com - March 27 at 7:00 AMGlycoMimetics Can Become A Game Changer In Blood Cancersseekingalpha.com - March 21 at 9:36 PMGlycoMimetics, Inc. (NASDAQ:GLYC) Short Interest Up 9.1% in Februarymarketbeat.com - March 19 at 5:37 PMGLYC Apr 2024 2.500 callfinance.yahoo.com - March 16 at 5:40 PMGLYC Apr 2024 2.500 putfinance.yahoo.com - March 16 at 12:39 PMGlycoMimetics Inc hosts conference call for investorsmarkets.businessinsider.com - March 16 at 12:39 PMGLYC Apr 2024 5.000 callfinance.yahoo.com - March 16 at 7:39 AMGlycoMimetics (NASDAQ:GLYC) Downgraded by StockNews.com to Sellmarketbeat.com - March 14 at 11:10 PMImmuneering cancer drug shows initial clinical activity in early-stage trialmsn.com - March 14 at 8:46 AMPalatin Technologies Inc.barrons.com - March 13 at 5:56 PMGlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024businesswire.com - March 13 at 7:00 AMGlycoMimetics Inc GLYCmorningstar.com - March 10 at 1:16 PMPositive Signs As Multiple Insiders Buy GlycoMimetics Stockfinance.yahoo.com - March 4 at 3:49 PMAcadian Asset Management LLC Sells 305,605 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC)marketbeat.com - February 28 at 5:45 AMGlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 26 at 9:01 AMGlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conferencebusinesswire.com - February 26 at 7:00 AMGlycoMimetics, Inc. (GKO.F)finance.yahoo.com - February 23 at 2:58 PMGlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)finance.yahoo.com - February 12 at 7:45 AMGlycoMimetics: Drug Approval Is Not Coming In 2024, But The Hype Could Be Realseekingalpha.com - January 30 at 5:10 PMGlycoMimetics Stock (NASDAQ:GLYC), Analyst Ratings, Price Targets, Predictionsbenzinga.com - January 5 at 2:09 PMGlycoMimetics' GMI-1687 Meets Primary Goal In Phase 1a Studymarkets.businessinsider.com - January 4 at 12:14 PMGlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687finance.yahoo.com - January 4 at 7:14 AMGlycoMimetics Stock (NASDAQ:GLYC) Dividends: History, Yield and Datesbenzinga.com - December 30 at 9:58 AMCapital One Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendationmsn.com - December 23 at 10:47 PMGlycoMimetics (NASDAQ:GLYC) Coverage Initiated at Capital One Financialmarketbeat.com - December 22 at 8:17 AMRetail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last weekfinance.yahoo.com - December 17 at 1:13 PMPromising Outlook for GlycoMimetics’ Uproleselan Drives Buy Ratingmarkets.businessinsider.com - December 12 at 9:13 AMGlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemiafinance.yahoo.com - December 10 at 12:47 PMGlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conferencefinance.yahoo.com - November 9 at 8:41 AMBuy Rating for GlycoMimetics: Stable Financials and Promising Drug Candidate Uproleselan Drive Positive Outlookmarkets.businessinsider.com - November 7 at 9:06 AMGlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 5 at 1:33 PMQ3 2023 GlycoMimetics Inc Earnings Callfinance.yahoo.com - November 4 at 8:02 AM Get GlycoMimetics News Delivered to You Automatically Sign up to receive the latest news and ratings for GLYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself GLYC Media Mentions By Week GLYC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLYC News Sentiment▼-0.250.33▲Average Medical News Sentiment GLYC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLYC Articles This Week▼51▲GLYC Articles Average Week Get GlycoMimetics News Delivered to You Automatically Sign up to receive the latest news and ratings for GLYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Societal CDMO News Repare Therapeutics News Immunic News Citius Pharmaceuticals News Abeona Therapeutics News Cartesian Therapeutics News Karyopharm Therapeutics News CytomX Therapeutics News Relmada Therapeutics News Adicet Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLYC) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Launch “FedNOW” [Move Your Money Now]Priority Gold😱 This phenomenon is smashing regular market gainsMillPubProtect Your Bank Account Before It’s Too LateWeiss RatingsYour bank is lying to you.MyBankTracker Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
